And thats close to 1billion syringes if I am not mistaken - growing at 15-25% per year. By the time the production facility is complete, it will not be able to supply 100% of Sanofi's requirements for RTFS. So I expect a much bigger extension further down the track (which is not a part of the current plans)
Sanofi should provide 50% of Unilife's revenue. The others will contribute the other $1billion+
- Forums
- ASX - By Stock
- UNS
- enough drama
enough drama, page-10
-
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add UNS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
Previous Video
Next Video
SPONSORED BY The Market Online